Literature DB >> 33232685

Effect of Sarcopenia Status on Disability Incidence Among Japanese Older Adults.

Hiroyuki Shimada1, Kota Tsutsumimoto2, Takehiko Doi2, Sangyoon Lee2, Seongryu Bae2, Sho Nakakubo2, Keitaro Makino2, Hidenori Arai3.   

Abstract

OBJECTIVES: The updated definition of sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP2) recommends both low muscle mass and quality to diagnose sarcopenia; concurrent poor physical performance is considered indicative of severe sarcopenia; however, the relationship between the revised definition and disability incidence among Japanese older adults is unclear. Therefore, we aimed to examine the associations between EWGSOP2-defined sarcopenia and disability incidence among community-dwelling older Japanese adults.
DESIGN: Nationwide study. SETTING AND PARTICIPANTS: We included 4561 individuals aged ≥65 years and enrolled in the National Center for Geriatrics and Gerontology-Study of Geriatric Syndromes (NCGG-SGS).
METHODS: Skeletal muscle mass was assessed using a bioimpedance analysis device; handgrip strength and walking speed were measured as physical performance indicators. We used the Asian Working Group for Sarcopenia cutoffs to define low muscle mass and poor physical performance. We stratified all participants into nonsarcopenia, sarcopenia, and severe sarcopenia groups. Disability incidence was prospectively determined over 49 months using data extracted from the Japanese long-term care insurance system.
RESULTS: The prevalence of sarcopenia and severe sarcopenia was 3.4% and 1.7%, respectively. Participants with any form of sarcopenia were at a higher risk of disability [hazard ratio (HR) 1.78, 95% confidence interval (CI) 1.27-2.49]. Although participants with severe sarcopenia showed a higher risk of disability (HR 2.00, 95% CI 1.32-3.02), there was no significant disability risk in the sarcopenia group (HR 1.54, 95% CI 0.97-2.46). Grip strength (HR 0.96, 95% CI 0.94-0.98) and walking speed (HR 0.19, 95% CI 0.12-0.30) negatively correlated with disability incidence. CONCLUSIONS AND IMPLICATIONS: Severe sarcopenia, involving low muscle mass and poor physical performance, might increase disability risk in older adults, as opposed to low muscle mass alone. Further studies are needed to determine whether sarcopenia without poor physical performance increases disability risk.
Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Japan; Sarcopenia; disability; low muscle mass; older adults; poor physical performance

Year:  2020        PMID: 33232685     DOI: 10.1016/j.jamda.2020.10.036

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  4 in total

1.  Differences in Health-Related Quality of Life in Older People with and without Sarcopenia Covered by Long-Term Care Insurance.

Authors:  Masahiro Kitamura; Kazuhiro P Izawa; Kodai Ishihara; Peter H Brubaker; Hiroaki Matsuda; Soichiro Okamura; Koji Fujioka
Journal:  Eur J Investig Health Psychol Educ       Date:  2022-05-26

2.  Longitudinal Association between Sarcopenia and Cognitive Impairment among Older Adults in Rural Malaysia.

Authors:  K Ramoo; Noran N Hairi; A Yahya; W Y Choo; F Mohd Hairi; D Peramalah; S Kandiben; A Bulgiba; Z Mohd Ali; I Abdul Razak; N Ismail; N S Ahmad
Journal:  Int J Environ Res Public Health       Date:  2022-04-14       Impact factor: 4.614

3.  Impact of Sarcopenia on Functional Outcomes Among Patients With Mild Acute Ischemic Stroke and Transient Ischemic Attack: A Retrospective Study.

Authors:  Hyungwoo Lee; Il Hyung Lee; JoonNyung Heo; Minyoul Baik; Hyungjong Park; Hye Sun Lee; Hyo Suk Nam; Young Dae Kim
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

4.  Risk factors for falls among community-dwelling older adults during voluntary self-isolation: analysis based on frailty screening index subscales.

Authors:  Akihiko Murayama; Daisuke Higuchi; Kosuke Saida; Shigeya Tanaka; Tomoyuki Shinohara
Journal:  J Phys Ther Sci       Date:  2022-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.